Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing

It is hoped that the drug zosurabalpin will be approved by the end of the decade

The Independent UK

Harris urges US against tariff hikes on pharma and microchip sectors

The Irish deputy premier has written to US Secretary for Commerce Howard Lutnick on two sectors that are key to Ireland’s economy.

Evening Standard

NHS rolls out ‘Amazon-style’ app for prescriptions to free up pharmacies

High street pharmacies including Boots have already adopted the technology

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying

Vigil Neuroscience tripled Thursday after Sanofi agreed to buy it for $470 million plus a CVR tied to its experimental Alzheimer's treatment.

Investors Business Daily

Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work

HHS unveiled the first details Tuesday on plans to tie U.S. drug prices to an international index, a so-called Most Favored Nation approach.

Investors Business Daily

Company decides not to rebuild chlorine plant with history of fires, explosions and toxic clouds

The company that operated a Georgia chlorine plant with a history of explosions and chemical fires that created toxic clouds has decided not to rebuild its Conyers manufacturing plant

The Independent UK

Bankrupt DNA testing firm 23andMe to be purchased for $256m

Drugmaker Regeneron Pharmaceuticals’ capture of genetic testing firm in bankruptcy auction raises privacy concerns

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection

The Independent UK

High Times For German Cannabis Firm Amid Medical Boom

At an undisclosed site in Germany's Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimetre (30-inch) thick steel door that secures his wares: vast amounts of cannabis.

International Business Times

FDA approves Novavax COVID-19 shot but with unusual restrictions

The Food and Drug Administration has approved Novavax's COVID-19 vaccine but with unusual restrictions

The Independent UK

Ozempic-maker Novo Nordisk Says CEO To Step Down

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

International Business Times

Stock Market Winners Look A Lot Alike: How To Use IBD's EPS Rating To Find Them

There's plenty of stock market winners that can perform well even if their EPS Rating isn't quite up to snuff.

Investors Business Daily

Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug

Biohaven shares plunged Thursday after the Food and Drug Administration unexpectedly delayed the review date for its rare-disease drug.

Investors Business Daily

French drug giant Sanofi plans massive US investment to counter Trump tariffs

French pharmaceutical giant Sanofi plans to invest billions of euros to expand its manufacturing in the United States, in response to President Donald Trump’s trade policies – which include threats to impose tariffs on medicines in order to increase homegrown production.

Radio France Internationale

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

RFK Jr orders mifepristone review as anti-abortion groups push for ban

Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government

Radio France Internationale

European court delivers blow to EU Commission over Von der Leyen-Pfizer texts

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission President Ursula von der Leyen and Pfizer’s CEO during the Covid-19 vaccine negotiations.

The Guardian - UK

Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court

European court of justice says no ‘plausible explanation’ given for denying New York Times access to texts from pandemic

Latin Times

RFK Jr. Admitting Big Pharma Paid Trump '$100 Million' Leaves Internet Stunned: 'Was That a Fraudian Slip?'

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.

International Business Times

Europe's Biggest 'Green' Methanol Plant Opens In Denmark

Europe's largest "green" methanol plant opened in Denmark on Tuesday, boosting the continent's emissions reduction efforts -- with customers ranging from shipping giant Maersk to toymaker Lego and pharmaceutical firm Novo Nordisk.

Evening Standard

Nationwide eye care product recall as experts warn to stop using this product immediately

More than 1.8 million units of this eye care solution have been recalled

The Guardian - US

Trump signs order aiming to slash US drug prices to match those abroad

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

Investors Business Daily

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'

Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.

Investors Business Daily

10 'Loser' Stocks Cost Investors 60% Of Their Money Over A Decade

The S&P 500 is a wealth generating machine over the long term. But investors are finding out the hard way it's possible to lose big, too.

Marie Claire

This serum is best-selling for a reason—it tackles everything from dryness to pigmentation, and costs less than £40

The ingredients lineup is impressive

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

592 stories

CMS

418 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.